Nifty
Sensex
:
:
11532.40
38363.47
70.20 (0.61%)
268.40 (0.70%)

Pharmaceuticals & Drugs

Rating :
64/99

BSE: 539523 | NSE: ALKEM

1772.90
-10.65 (-0.60%)
19-Mar-2019 | 3:57PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1783.60
  •  1816.00
  •  1750.00
  •  1783.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  67295
  •  1193.07
  •  2268.00
  •  1702.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 21,266.43
  • 32.21
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,687.21
  • 0.73%
  • 3.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 65.98%
  • 2.57%
  • 23.45%
  • FII
  • DII
  • Others
  • 0.09%
  • 4.72%
  • 3.19%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.40
  • 15.49
  • 9.25

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.23
  • 20.19
  • 3.80

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.47
  • 7.71
  • -5.24

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 30.87

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 4.86

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 19.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
1,925.03
1,741.19
10.56%
1,918.92
1,858.98
3.22%
1,669.46
1,312.54
27.19%
1,513.23
1,251.40
20.92%
Expenses
1,613.25
1,380.66
16.85%
1,554.75
1,404.48
10.70%
1,455.23
1,218.17
19.46%
1,399.48
1,102.14
26.98%
EBITDA
311.78
360.53
-13.52%
364.17
454.50
-19.87%
214.23
94.37
127.01%
113.75
149.26
-23.79%
EBIDTM
16.20%
20.71%
18.98%
24.45%
12.83%
7.19%
7.52%
11.93%
Other Income
9.35
23.86
-60.81%
24.02
29.97
-19.85%
16.25
29.49
-44.90%
17.87
24.61
-27.39%
Interest
15.38
14.48
6.22%
16.40
17.85
-8.12%
16.26
12.56
29.46%
10.44
11.45
-8.82%
Depreciation
47.69
37.50
27.17%
45.77
34.57
32.40%
42.45
30.63
38.59%
40.33
26.37
52.94%
PBT
258.06
332.41
-22.37%
326.02
432.05
-24.54%
171.77
80.67
112.93%
80.85
136.05
-40.57%
Tax
52.61
151.54
-65.28%
65.60
104.61
-37.29%
34.50
16.89
104.26%
14.52
-0.91
-
PAT
205.45
180.87
13.59%
260.42
327.44
-20.47%
137.27
63.78
115.22%
66.33
136.96
-51.57%
PATM
10.67%
10.39%
13.57%
17.61%
8.22%
4.86%
4.38%
10.94%
EPS
16.94
14.36
17.97%
21.29
26.82
-20.62%
11.39
5.99
90.15%
5.61
11.46
-51.05%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
7,026.64
6,421.85
5,687.53
4,924.84
3,743.35
3,126.00
2,495.23
2,015.64
1,690.79
Net Sales Growth
13.99%
12.91%
15.49%
31.56%
19.75%
25.28%
23.79%
19.21%
 
Cost Of Goods Sold
2,869.08
2,116.59
1,807.71
1,630.87
1,453.41
1,168.05
866.74
645.76
597.04
Gross Profit
4,157.56
4,305.26
3,879.82
3,293.97
2,289.94
1,957.95
1,628.49
1,369.88
1,093.75
GP Margin
59.17%
67.04%
68.22%
66.88%
61.17%
62.63%
65.26%
67.96%
64.69%
Total Expenditure
6,022.71
5,393.46
4,688.58
4,071.59
3,321.52
2,716.05
2,132.78
1,640.43
1,404.20
Power & Fuel Cost
-
112.64
86.34
66.33
53.31
60.33
53.17
50.68
37.78
% Of Sales
-
1.75%
1.52%
1.35%
1.42%
1.93%
2.13%
2.51%
2.23%
Employee Cost
-
1,191.64
1,003.85
861.08
645.87
531.56
412.29
303.45
267.09
% Of Sales
-
18.56%
17.65%
17.48%
17.25%
17.00%
16.52%
15.05%
15.80%
Manufacturing Exp.
-
708.72
692.26
550.16
367.58
305.99
264.84
234.61
195.99
% Of Sales
-
11.04%
12.17%
11.17%
9.82%
9.79%
10.61%
11.64%
11.59%
General & Admin Exp.
-
413.80
377.69
331.27
238.45
184.73
180.17
139.46
106.32
% Of Sales
-
6.44%
6.64%
6.73%
6.37%
5.91%
7.22%
6.92%
6.29%
Selling & Distn. Exp.
-
685.97
596.44
503.69
434.56
367.31
295.39
226.31
167.01
% Of Sales
-
10.68%
10.49%
10.23%
11.61%
11.75%
11.84%
11.23%
9.88%
Miscellaneous Exp.
-
164.10
124.29
128.19
128.34
98.08
60.18
40.16
32.97
% Of Sales
-
2.56%
2.19%
2.60%
3.43%
3.14%
2.41%
1.99%
1.95%
EBITDA
1,003.93
1,028.39
998.95
853.25
421.83
409.95
362.45
375.21
286.59
EBITDA Margin
14.29%
16.01%
17.56%
17.33%
11.27%
13.11%
14.53%
18.61%
16.95%
Other Income
67.49
95.95
112.01
239.71
181.04
165.35
167.17
145.28
113.42
Interest
58.48
55.33
45.16
71.24
81.11
93.08
88.23
58.10
41.23
Depreciation
176.24
143.03
101.17
93.31
70.94
52.26
39.79
29.03
27.43
PBT
836.70
925.98
964.63
928.41
450.82
429.96
401.60
433.36
331.35
Tax
167.23
287.56
59.96
176.18
59.23
-5.36
17.97
27.52
35.57
Tax Rate
19.99%
31.05%
6.22%
18.98%
13.14%
-1.25%
4.47%
6.35%
10.73%
PAT
669.47
630.94
892.03
741.59
391.59
435.32
383.82
406.54
295.59
PAT before Minority Interest
660.23
638.42
904.67
752.23
391.59
435.32
383.63
405.84
295.78
Minority Interest
-9.24
-7.48
-12.64
-10.64
0.00
0.00
0.19
0.70
-0.19
PAT Margin
9.53%
9.82%
15.68%
15.06%
10.46%
13.93%
15.38%
20.17%
17.48%
PAT Growth
-5.58%
-29.27%
20.29%
89.38%
-10.05%
13.42%
-5.59%
37.54%
 
Unadjusted EPS
55.23
52.77
74.61
62.02
32.75
364.09
321.01
339.43
247.38

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
4,863.77
4,467.64
3,691.96
3,002.63
2,584.97
2,177.31
1,820.05
1,433.69
Share Capital
23.91
23.91
23.91
23.91
11.96
11.96
11.96
11.96
Total Reserves
4,838.87
4,443.34
3,668.03
2,978.72
2,573.01
2,165.35
1,808.09
1,421.73
Non-Current Liabilities
-358.61
-400.78
-306.15
197.02
323.92
361.67
524.89
434.40
Secured Loans
122.12
175.01
112.49
33.43
232.25
255.57
308.97
246.26
Unsecured Loans
8.61
6.55
10.97
0.00
0.00
0.02
0.00
0.00
Long Term Provisions
150.27
102.17
82.96
66.58
42.29
44.30
179.99
162.14
Current Liabilities
2,383.31
1,689.69
1,537.60
2,005.98
1,402.58
1,731.80
1,120.59
981.86
Trade Payables
960.71
741.37
580.48
465.93
305.73
287.59
276.03
167.69
Other Current Liabilities
520.04
339.25
366.01
327.06
201.28
187.74
111.47
87.39
Short Term Borrowings
761.27
472.37
464.17
1,128.57
845.22
1,210.17
670.31
663.10
Short Term Provisions
141.29
136.70
126.94
84.42
50.35
46.30
62.78
63.68
Total Liabilities
7,010.02
5,871.78
5,018.43
5,291.28
4,311.47
4,270.78
3,465.72
2,851.77
Net Block
2,283.60
1,797.04
1,449.54
1,374.34
1,170.01
1,072.12
919.17
692.73
Gross Block
2,603.78
1,977.20
1,538.64
1,744.89
1,170.01
1,072.12
919.17
692.73
Accumulated Depreciation
320.18
180.16
89.10
370.55
0.00
0.00
0.00
0.00
Non Current Assets
3,094.83
2,954.64
2,249.73
2,953.23
2,709.33
2,114.56
2,153.43
1,313.22
Capital Work in Progress
380.97
299.26
172.42
110.69
0.00
0.00
0.00
0.00
Non Current Investment
196.47
259.44
234.39
419.73
338.24
410.33
298.91
6.10
Long Term Loans & Adv.
141.37
193.07
142.35
542.17
418.40
339.39
258.82
153.98
Other Non Current Assets
92.42
405.83
251.03
506.30
782.68
292.72
676.53
460.41
Current Assets
3,915.19
2,917.14
2,768.70
2,338.05
1,602.14
2,156.22
1,312.29
1,538.55
Current Investments
247.80
293.56
274.18
61.05
249.77
67.31
23.78
47.70
Inventories
1,442.19
1,206.00
909.37
784.23
620.33
553.96
384.92
250.87
Sundry Debtors
1,080.50
713.64
567.51
527.08
366.93
318.21
246.61
171.02
Cash & Bank
576.78
399.26
780.90
790.76
206.29
995.45
513.81
989.82
Other Current Assets
567.92
133.33
95.44
60.08
158.82
221.29
143.17
79.14
Short Term Loans & Adv.
390.62
171.35
141.30
114.85
110.04
115.29
80.24
40.32
Net Current Assets
1,531.88
1,227.45
1,231.10
332.07
199.56
424.42
191.70
0.00
Total Assets
7,010.02
5,871.78
5,018.43
5,291.28
4,311.47
4,270.78
3,465.72
2,851.77

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
276.18
471.14
725.83
328.14
290.01
78.05
159.05
147.93
PBT
925.98
964.63
928.41
514.16
429.96
401.60
433.36
331.35
Adjustment
116.85
33.02
-14.42
15.89
7.48
-30.64
-32.93
-17.61
Changes in Working Capital
-563.48
-262.55
10.05
-96.27
-36.37
-182.68
-144.78
-99.22
Cash after chg. in Working capital
479.35
735.10
924.04
433.78
401.07
188.28
255.65
214.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-203.17
-263.96
-198.21
-105.64
-111.06
-110.23
-96.60
-66.59
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-367.37
-285.93
202.27
-237.00
350.44
-403.52
-247.50
-822.79
Net Fixed Assets
-531.27
-390.07
160.79
-111.90
-103.11
-213.73
-206.97
Net Investments
-26.86
-359.97
-87.11
-129.77
-361.40
-207.20
-318.96
Others
190.76
464.11
128.59
4.67
814.95
17.41
278.43
Cash from Financing Activity
84.56
-137.88
-927.27
-51.79
-599.94
355.64
-11.07
778.87
Net Cash Inflow / Outflow
-6.63
47.33
0.83
39.35
40.51
30.17
-99.52
104.01
Opening Cash & Equivalents
166.63
127.03
123.75
100.82
57.31
26.35
123.96
19.98
Closing Cash & Equivalent
166.71
166.63
127.05
139.60
100.82
57.31
26.35
123.96

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
406.76
373.67
308.82
251.16
216.13
182.05
152.18
0.00
ROA
9.91%
16.61%
14.59%
8.16%
10.14%
9.92%
12.85%
10.37%
ROE
13.69%
22.18%
22.47%
14.02%
18.28%
19.19%
24.95%
20.63%
ROCE
17.86%
21.31%
23.09%
13.26%
14.06%
14.96%
19.02%
15.90%
Fixed Asset Turnover
2.81
3.33
3.07
2.65
2.89
2.59
2.57
2.49
Receivable days
50.91
39.95
39.57
42.27
38.62
40.02
36.80
36.14
Inventory Days
75.15
65.96
61.23
66.41
66.19
66.53
56.02
53.01
Payable days
60.92
52.36
49.96
45.83
42.61
49.36
50.29
47.05
Cash Conversion Cycle
65.15
53.55
50.84
62.85
62.19
57.20
42.53
42.10
Total Debt/Equity
0.21
0.15
0.18
0.43
0.44
0.71
0.55
0.00
Interest Cover
17.74
22.36
14.03
6.56
5.62
5.55
8.46
9.04

Annual Reports:

News Update:


  • Alkem Laboratories - Quarterly Results
    8th Feb 2019, 13:42 PM

    Read More
  • USFDA conducts inspection at Alkem Laboratories’ facility at St Louis
    6th Feb 2019, 15:16 PM

    At the end of inspection, the company has received Form 483 that contains eight observations

    Read More
  • USFDA conducts inspection at Alkem Laboratories’ facility at Daman
    18th Jan 2019, 15:06 PM

    After the inspection there were no observation found

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.